Skip to main content

Table 2 Examples of advances in LLPS-based resistance against lung cancer

From: New insights into the important roles of phase seperation in the targeted therapy of lung cancer

Targets

Types

Functions

References

Inhibitors related to the YAP phase seperation process

EVG

Disrupt the LLPS of the SRC-1 protein

[66]

 

Verteporfin

Sequester YAP in the cytoplasm and disrupt the formation of YAP-containing liquid droplets in cancer cells

[63]

 

Peptidomimetics

Disrupt the interaction between YAP and the transcriptional co-activator TEAD

[53]

 

YAP-Tead interaction inhibitors

Disrupt the interaction between YAP and the transcriptional co-activator TEAD

[53]

Inhibitors related to the EGFR phase seperation process

SHP099

SHP2 inhibitor

[57]

Drugs affecting the process of LLPS

1,6-Hexanediol

Disrupt the LLPS process of various proteins

[25]

Delivery systems

Liposomes

Encapsulate a variety of drugs and other therapeutic agents

[64]